StockData
Denali Therapeutics Inc. logo

Denali Therapeutics Inc. (DNLI) stock

DNLINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$18.00−0.08 (-0.44%)

Close on Nov 17, 2026Market cap $2.88BP/E –Yield –

Denali Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Denali Therapeutics's market cap was $3.15B on Nov 11, 2026, against $2.85B a year earlier. Over the last 5 years it ranged from $1.92B to $5.44B, with a median of $3.30B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.15B+30.2%
2025Dec 31, 2025$2.42B-17.4%
2024Dec 31, 2024$2.93B-1.1%
2023Dec 29, 2023$2.96B-13.9%
2022Dec 30, 2022$3.44B-36.7%
2021Dec 31, 2021$5.44B-45.8%
2020Dec 31, 2020$10.03B+500.1%
2019Dec 31, 2019$1.67B-13.9%
2018Dec 31, 2018$1.94B+1832.2%
2017Dec 29, 2017$100.48M–

More Denali Therapeutics figures

See a number that looks wrong?